Literature DB >> 17404618

Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans.

Liesbeth Van Wesenbeeck1, Paul R Odgren, Fraser P Coxon, Annalisa Frattini, Pierre Moens, Bram Perdu, Carole A MacKay, Els Van Hul, Jean-Pierre Timmermans, Filip Vanhoenacker, Ruben Jacobs, Barbara Peruzzi, Anna Teti, Miep H Helfrich, Michael J Rogers, Anna Villa, Wim Van Hul.   

Abstract

This study illustrates that Plekhm1 is an essential protein for bone resorption, as loss-of-function mutations were found to underlie the osteopetrotic phenotype of the incisors absent rat as well as an intermediate type of human osteopetrosis. Electron and confocal microscopic analysis demonstrated that monocytes from a patient homozygous for the mutation differentiated into osteoclasts normally, but when cultured on dentine discs, the osteoclasts failed to form ruffled borders and showed little evidence of bone resorption. The presence of both RUN and pleckstrin homology domains suggests that Plekhm1 may be linked to small GTPase signaling. We found that Plekhm1 colocalized with Rab7 to late endosomal/lysosomal vesicles in HEK293 and osteoclast-like cells, an effect that was dependent on the prenylation of Rab7. In conclusion, we believe PLEKHM1 to be a novel gene implicated in the development of osteopetrosis, with a putative critical function in vesicular transport in the osteoclast.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404618      PMCID: PMC1838941          DOI: 10.1172/JCI30328

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  68 in total

1.  Role of the FYVE finger and the RUN domain for the subcellular localization of Rabip4.

Authors:  M Mari; E Macia; Y Le Marchand-Brustel; M Cormont
Journal:  J Biol Chem       Date:  2001-08-16       Impact factor: 5.157

2.  Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption.

Authors:  H Zhao; T Laitala-Leinonen; V Parikka; H K Väänänen
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

3.  Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts.

Authors:  Yi Sun; Kalman G Büki; Otto Ettala; Jukka P Vääräniemi; H Kalervo Väänänen
Journal:  J Biol Chem       Date:  2005-07-21       Impact factor: 5.157

4.  A novel method for efficient generation of transfected human osteoclasts.

Authors:  A Taylor; M J Rogers; D Tosh; F P Coxon
Journal:  Calcif Tissue Int       Date:  2007-02-03       Impact factor: 4.333

Review 5.  Podosome and sealing zone: specificity of the osteoclast model.

Authors:  Pierre Jurdic; Frédéric Saltel; Anne Chabadel; Olivier Destaing
Journal:  Eur J Cell Biol       Date:  2005-10-24       Impact factor: 4.492

6.  Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement.

Authors:  Alessandra Pangrazio; Pietro Luigi Poliani; André Megarbane; Gérard Lefranc; Edoardo Lanino; Maja Di Rocco; Francesca Rucci; Franco Lucchini; Maria Ravanini; Fabio Facchetti; Mario Abinun; Paolo Vezzoni; Anna Villa; Annalisa Frattini
Journal:  J Bone Miner Res       Date:  2006-07       Impact factor: 6.741

Review 7.  A clinical and molecular overview of the human osteopetroses.

Authors:  W Balemans; L Van Wesenbeeck; W Van Hul
Journal:  Calcif Tissue Int       Date:  2005-11-16       Impact factor: 4.333

8.  Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases.

Authors:  James E Dunford; Michael J Rogers; Frank H Ebetino; Roger J Phipps; Fraser P Coxon
Journal:  J Bone Miner Res       Date:  2006-05       Impact factor: 6.741

9.  Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis.

Authors:  Keith Thompson; Michael J Rogers; Fraser P Coxon; Julie C Crockett
Journal:  Mol Pharmacol       Date:  2006-02-24       Impact factor: 4.436

10.  Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.

Authors:  A Del Fattore; B Peruzzi; N Rucci; I Recchia; A Cappariello; M Longo; D Fortunati; P Ballanti; M Iacobini; M Luciani; R Devito; R Pinto; M Caniglia; E Lanino; C Messina; S Cesaro; C Letizia; G Bianchini; H Fryssira; P Grabowski; N Shaw; N Bishop; D Hughes; R P Kapur; H K Datta; A Taranta; R Fornari; S Migliaccio; A Teti
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

View more
  68 in total

Review 1.  New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.

Authors:  J C Crockett; D J Mellis; D I Scott; M H Helfrich
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Two novel CAII mutations causing carbonic anhydrase II deficiency syndrome in two unrelated Chinese families.

Authors:  Qianqian Pang; Xuan Qi; Yan Jiang; Ou Wang; Mei Li; Xiaoping Xing; Jin Dong; Weibo Xia
Journal:  Metab Brain Dis       Date:  2015-02-27       Impact factor: 3.584

Review 3.  Regulation of lysosome biogenesis and functions in osteoclasts.

Authors:  Julie Lacombe; Gérard Karsenty; Mathieu Ferron
Journal:  Cell Cycle       Date:  2013-08-05       Impact factor: 4.534

4.  Novel mutation of TCIRG1 and clinical pictures of two infantile malignant osteopetrosis patients.

Authors:  Ping Yuan; Zhihui Yue; Liangzhong Sun; Weijun Huang; Bin Hu; Zhiyun Yang; Yuelin Hu; Hua Xiao; Hui Shi; Qing Zhou; Yiming Wang
Journal:  J Bone Miner Metab       Date:  2010-11-02       Impact factor: 2.626

5.  Genome-wide association identifies three new susceptibility loci for Paget's disease of bone.

Authors:  Omar M E Albagha; Sachin E Wani; Micaela R Visconti; Nerea Alonso; Kirsteen Goodman; Maria Luisa Brandi; Tim Cundy; Pui Yan Jenny Chung; Rosemary Dargie; Jean-Pierre Devogelaer; Alberto Falchetti; William D Fraser; Luigi Gennari; Fernando Gianfrancesco; Michael J Hooper; Wim Van Hul; Gianluca Isaia; Geoff C Nicholson; Ranuccio Nuti; Socrates Papapoulos; Javier del Pino Montes; Thomas Ratajczak; Sarah L Rea; Domenico Rendina; Rogelio Gonzalez-Sarmiento; Marco Di Stefano; Lynley C Ward; John P Walsh; Stuart H Ralston
Journal:  Nat Genet       Date:  2011-05-29       Impact factor: 38.330

6.  A novel CLCN7 mutation resulting in a most severe form of autosomal recessive osteopetrosis.

Authors:  Nesrin Besbas; Markus Draaken; Michael Ludwig; Ozgur Deren; Diclehan Orhan; Yelda Bilginer; Fatih Ozaltin
Journal:  Eur J Pediatr       Date:  2009-02-24       Impact factor: 3.183

Review 7.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

Review 8.  Osteopetrosis.

Authors:  Zornitza Stark; Ravi Savarirayan
Journal:  Orphanet J Rare Dis       Date:  2009-02-20       Impact factor: 4.123

9.  Osteopetrosis with micro-lacunar resorption because of defective integrin organization.

Authors:  Harry C Blair; Beatrice B Yaroslavskiy; Lisa J Robinson; Markus Y Mapara; Alessandra Pangrazio; Lida Guo; Ka Chen; Paolo Vezzoni; Jakub Tolar; Paul J Orchard
Journal:  Lab Invest       Date:  2009-06-22       Impact factor: 5.662

10.  Discovery of candidate disease genes in ENU-induced mouse mutants by large-scale sequencing, including a splice-site mutation in nucleoredoxin.

Authors:  Melissa K Boles; Bonney M Wilkinson; Laurens G Wilming; Bin Liu; Frank J Probst; Jennifer Harrow; Darren Grafham; Kathryn E Hentges; Lanette P Woodward; Andrea Maxwell; Karen Mitchell; Michael D Risley; Randy Johnson; Karen Hirschi; James R Lupski; Yosuke Funato; Hiroaki Miki; Pablo Marin-Garcia; Lucy Matthews; Alison J Coffey; Anne Parker; Tim J Hubbard; Jane Rogers; Allan Bradley; David J Adams; Monica J Justice
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.